Cancer patients with opioid use disorder face obstacles to treatment

A cancer diagnosis can disrupt treatment with substitute-drug methadone. Through the lens of 1 patient treated with methadone for years and later diagnosed with head and neck cancer, University of Pittsburgh researchers discuss segregating methadone distribution from general medical care, the need to integrate opioid use disorder treatment, and improve patient access.